Filter by: patients

Treatments Reported by Patients with MS (Multiple Sclerosis)

40.4% of the 27,700 patients with MS (Multiple Sclerosis) report taking at least one of these treatments to modify their disease or manage its symptoms.

Treatment # Patients
Glatiramer acetate (Copaxone) 3444 12% Glatiramer acetate (Copaxone): 12%
Baclofen (Mylan Baclofen, Miorel...) 2517 9% Baclofen (Mylan Baclofen, Miorel...): 9%
Interferon beta-1a SubQ injection (Rebif) 1877 7% Interferon beta-1a SubQ injection (Rebif): 7%
Interferon beta-1a IM Injection (Avonex, Avonex Prefilled Syringe) 1520 5% Interferon beta-1a IM Injection (Avonex, Avonex Prefilled Syringe): 5%
Natalizumab (Tysabri, Antegren) 1405 5% Natalizumab (Tysabri, Antegren): 5%
Modafinil (Provigil, Modiodal...) 1314 5% Modafinil (Provigil, Modiodal...): 5%
Interferon beta-1b SubQ Injection (Betaseron, Betaferon...) 994 4% Interferon beta-1b SubQ Injection (Betaseron, Betaferon...): 4%
Dalfampridine (4-AP extended release) (Ampyra) 706 3% Dalfampridine (4-AP extended release) (Ampyra): 3%
Fingolimod (Gilenya) 290 1% Fingolimod (Gilenya): 1%
Mitoxantrone (Novantrone) 70 0% Mitoxantrone (Novantrone): 0%

Community Treatment Reports

Click on a treatment to see what patients with MS (Multiple Sclerosis) have to say about side-effects, efficacy, advice, burden, dosages and cost of any treatment they're taking for any condition.